Related Experiment Video

Updated: Aug 30, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Hypercholesterolemia as cardiovascular risk in hypertensive patients. Therapeutic implications: efficiency of

Claudio Borghi1, Maddalena Veronesi

  • 1Divisione di Medicina Interna, Dipartimento di Medicina Clinica e Biotecnologia Applicata, Università Alma Mater Studiorum, Bologna. claudio@med.unibo.it

Recenti Progressi in Medicina
|November 19, 2003
PubMed

Insights

Hypertension and high cholesterol increase cardiovascular disease risk. Treating both simultaneously, particularly with statins, may improve patient outcomes and reduce blood pressure.

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Epidemiological studies link hypertension with elevated serum cholesterol, a significant cardiovascular disease risk factor.
  • Limited large clinical trial data exist on the impact of combined therapeutic interventions for cardiovascular risk.
  • Hypercholesterolemia and hypertension frequently coexist, increasing the need for effective management strategies.

Purpose:

  • To review the scientific evidence on the role of hypolipidemic drugs, particularly statins, in managing coexisting hypercholesterolemia and hypertension.
  • To explore the synergistic effects of statins with antihypertensive drugs in hypertensive hypercholesterolemic patients.

Summary:

  • Statins have demonstrated efficacy in improving lipid profiles in hypercholesterolemic individuals.
  • Clinical studies indicate that statins can also lower blood pressure in hypertensive hypercholesterolemic subjects.
  • These effects are potentiated when statins are used in conjunction with certain antihypertensive medications.

Impact:

  • Combined treatment strategies targeting both hypertension and hypercholesterolemia are crucial for improving cardiovascular risk profiles.
  • Statins offer a dual benefit by managing lipid levels and contributing to blood pressure reduction.
  • Further research and clinical trials are warranted to fully elucidate the long-term impact of these combined interventions.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...